TY  - GEN
AU  - Galle,Eva
AU  - Thienpont,Bernard
AU  - Cappuyns,Sarah
AU  - Venken,Tom
AU  - Busschaert,Pieter
AU  - Van Haele,Matthias
AU  - Van Cutsem,Eric
AU  - Roskams,Tania
AU  - van Pelt,Jos
AU  - Verslype,Chris
AU  - Dekervel,Jeroen
AU  - Lambrechts,Diether
TI  - DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
SN  - 1868-7083
PY  - 2021///0602
KW  - Azacitidine
KW  - therapeutic use
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - drug effects
KW  - Circulating Tumor DNA
KW  - genetics
KW  - DNA Methylation
KW  - Drug Resistance, Neoplasm
KW  - Enzyme Inhibitors
KW  - Epigenesis, Genetic
KW  - Epithelial-Mesenchymal Transition
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Liver Neoplasms
KW  - pathology
KW  - MicroRNAs
KW  - Protein Kinase Inhibitors
KW  - Sorafenib
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/s13148-020-0821-z
ER  -